Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC

Darolutamide plus ADT provides deep and durable PSA responses in metastatic hormone-sensitive prostate cancer

Transperineal biopsy improves prostate cancer detection

Adjuvant docetaxel shows no significant advantage compared to surveillance in high-risk prostate cancer after 10 years

TAR-200 plus cetrelimab show encouraging outcomes for MIBC patients ineligible for standard cisplatin-based chemotherapy

EAU 2025: Updates in NMIBC

Enzalutamide with 5-ARI is safe for older patients with castration-sensitive systemic prostate cancer

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients

Boost IORT in breast cancer: Peruvian experience

Intraoperative radiotherapy for brain tumours

Higher visceral fat linked to reduced overall survival in older adults with newly diagnosed gastrointestinal malignancies

Talazoparib and enzalutamide combination therapy shows significant benefit in treating mCRPC